SMTL ID : 6xkr.1

Structure of Sasanlimab Fab in complex with PD-1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.59 Å

Oligo State

hetero-1-1-1-mer

Ligands

5 x GOL: GLYCEROL(Non-functional Binders)

GOL.1: 5 residues within 4Å: Chain A: P.41, A.172, V.173, L.174, Y.180 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.152, A:L.174 GOL.2: 2 residues within 4Å: Chain A: P.217, K.218 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:P.217 GOL.3: 11 residues within 4Å: Chain A: F.170, P.171, V.173, S.181, L.182, S.183 Chain B: Q.166, S.168, S.182, S.183, T.184 6 PLIP interactions: 3 interactions with chain B, 3 interactions with chain A Hydrogen bonds: B:Q.166, B:S.168, B:T.184, A:P.171, A:S.183, A:S.183 GOL.4: 4 residues within 4Å: Chain B: S.14, K.113, R.114, T.115 2 PLIP interactions: 2 interactions with chain B Water bridges: B:L.15, B:K.113 GOL.5: 3 residues within 4Å: Chain B: D.9, G.106, G.107 No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Al-Khami, A.A. et al., Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 Antibody. Mol.Cancer Ther. (2020)

Release Date

2020-09-09

Peptides

Sasanlimab Fab Heavy chain: A
Sasanlimab Fab Light chain: B
Programmed cell death protein 1: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
P

Sasanlimab Fab Heavy chain

Sasanlimab Fab Light chain

Programmed cell death protein 1